Allianz Asset Management Gmb H Maravai Lifesciences Holdings, Inc. Transaction History

Allianz Asset Management Gmb H

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$5.11 - $8.76 $976,521 - $1.67 Million	191,100 New	191,100 $1.66 Million
Q2 2023 Aug 11, 2023	SELL	$12.09 - $15.0 $442,518 - $549,030	-36,602 Reduced 52.53%	33,079 $411,000
Q1 2023 May 11, 2023	BUY	$12.99 - $16.48 $905,156 - $1.15 Million	69,681 New	69,681 $976,000
Q2 2022 Aug 12, 2022	BUY	$26.05 - $37.48 $616,785 - $887,413	23,677 Added 58.28%	64,305 $1.83 Million
Q1 2022 May 13, 2022	SELL	$24.46 - $40.92 $431,988 - $722,688	-17,661 Reduced 30.3%	40,628 $1.43 Million
Q4 2021 Feb 11, 2022	BUY	$35.0 - $45.94 $778,435 - $1.02 Million	22,241 Added 61.7%	58,289 $2.44 Million
Q3 2021 Nov 10, 2021	SELL	$36.8 - $60.62 $278,649 - $459,014	-7,572 Reduced 17.36%	36,048 $1.77 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $45.0 $21.8 Million - $30.2 Million	-671,187 Reduced 93.9%	43,620 $1.82 Million
Q1 2021 May 13, 2021	SELL	$25.8 - $38.49 $10.4 Million - $15.5 Million	-401,543 Reduced 35.97%	714,807 $25.5 Million
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $27.4 Million - $34.5 Million	1,116,350 New	1,116,350 $31.3 Million

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $739M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.